Vita Coco updates director committee roles
The Vita Coco Company, Inc. filed an amended current report to update the responsibilities of recently appointed director Shelley Broader.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K/A
Rhea-AI Filing Summary
The Vita Coco Company, Inc. filed an amended current report to update the responsibilities of recently appointed director Shelley Broader. She joined the Board on January 7, 2026, and on April 17, 2026, the Board appointed her to the Audit Committee and the Compensation Committee.
Her committee service will be effective June 3, 2026, following the Company’s 2026 Annual Meeting of Stockholders. The filing is signed by Chief Executive Officer Martin Roper on behalf of the Company.
8-K Event Classification
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
1 item
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Key Terms
Audit Committee, Compensation Committee, Item 5.02, Emerging growth company
4 terms
Audit Committee financial
"the Board appointed Ms. Broader to serve as a member of the Audit Committee"
A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.
Compensation Committee financial
"and the Compensation Committee effective June 3, 2026"
A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.
Item 5.02 regulatory
"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers"
Item 5.02 is a specific disclosure category on the U.S. Securities and Exchange Commission’s Form 8‑K that requires public companies to report changes in key personnel and related compensation arrangements. It covers departures and appointments of directors and certain officers, elections of directors, and new or material changes to compensatory agreements for those persons; the company must file a Form 8‑K with the required information and any related exhibits within the SEC’s prescribed reporting timeframe. The item is a rule‑based reporting obligation under U.S. securities law, so its scope and timing follow the SEC’s definitions and deadlines rather than informal usage.
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What change does The Vita Coco Company (COCO) report in this 8-K/A?
The company reports updated responsibilities for director Shelley Broader. The Board appointed her to the Audit Committee and the Compensation Committee on April 17, 2026, with those roles effective June 3, 2026, after the 2026 Annual Meeting of Stockholders.
Who is Shelley Broader in relation to The Vita Coco Company (COCO)?
Shelley Broader is a member of The Vita Coco Company’s Board of Directors. She was appointed to the Board on January 7, 2026, and later designated to serve on the Audit Committee and the Compensation Committee effective June 3, 2026.
When will Shelley Broader’s committee appointments at COCO become effective?
Her committee roles become effective June 3, 2026. The Board decided on April 17, 2026 that she will serve on the Audit Committee and the Compensation Committee, with her service starting after the 2026 Annual Meeting of Stockholders.
Which Board committees will Shelley Broader serve on at The Vita Coco Company (COCO)?
She will serve on the Audit Committee and the Compensation Committee of The Vita Coco Company’s Board. The Board resolved these assignments on April 17, 2026, with both roles effective on June 3, 2026, following the 2026 Annual Meeting of Stockholders.
What earlier filing is referenced in this Vita Coco (COCO) 8-K/A amendment?
The amendment references a prior report filed on January 8, 2026. That earlier report announced Shelley Broader’s appointment to the Board on January 7, 2026, before the Board had determined her specific committee assignments.
AI-generated analysis. How Rhea-AI works. Not financial advice.
